UpdatesGeneral Updates
Vilin Bio Med is incorporating two wholly-owned subsidiaries: Vilo Speciality Pharma to focus on Oncology products, and Axia Pharma for general & generic pharmaceuticals.
Vilin Bio Med LimitedVILINBIO · Filed with the exchange
Each new entity has a proposed authorized capital of 0.1 Cr, signaling strategic expansion in the pharma sector.
No comments yet. Be the first.